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Here we describe a lineage reprogramming system
consisting of a B cell line with an estradiol-inducible
form of C/EBPa where cells can be converted into
macrophage-like cells at 100% efficiency within 2 to
3 days. The reprogrammed cells are larger, contain
altered organelle and cytoskeletal structures, are
phagocytic, and exhibit an inflammatory response.
Time-lapse experiments showed that the cells
acquire a macrophage morphology and increased
migratory activity as early as 10 hr. During induction,
thousands of genes become up- or downregulated,
including several dozen transcription and chro-
matin-remodeling factors. Time-limited exposure of
cells to the inducer showed that the reprogrammed
cells become transgene independent within 1 to 2
days. The reprogramming can be inhibited, at least
partially, by perturbation experiments with B cell
andmacrophage transcription factors. The tightness,
robustness, andspeedof the systemdescribedmake
it a versatile tool to study biochemical and biological
aspects of lineage reprogramming.
INTRODUCTION
Harold Weintraub’s laboratory showed that a single gene, en-
coding the transcription factor MyoD, can induce the differentia-
tion of fibroblasts into myotubes (Davis et al., 1987). The subse-
quent finding that MyoD can also induce the expression of
muscle genes in cell lines of ectodermal and endodermal origin
(Weintraub et al., 1989) raised the possibility that fully specialized
cells can be reprogrammed into other cell types. Indeed, exper-
iments with avian myeloid leukemia cells showed that GATA-1
can convert the cells into megakaryocytic/erythroid cells. The
cells not only activated genes of the megakaryocytic/erythroid
lineage but also downregulated macrophage genes (Kulessa
et al., 1995). Since then, transcription factors have been used
to reprogram a number of other tissues, such as cultured astro-
cytes into neuronal cells by Pax6 (Heins et al., 2002); pancreatic
cells into liver cells by activation of C/EBPb (Shen et al., 2003);
B cells into macrophages by C/EBPa (Xie et al., 2004); and554 Cell Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Iembryonic stem cells into the trophectoderm by Cdx2 (Niwa
et al., 2005). Direct reprogramming of specialized cells has
also been shown in vivo. Thus, an activated form of Pdx1 induces
hepatic cells to turn into pancreatic beta islet cells in Xenopus
(Horb et al., 2003). More recently, a combination of Pdx1 with
Ngn1 and MafA was shown to reprogram exocrine cells into
beta islet cells in the mouse pancreas (Zhou et al., 2008). Given
enough knowledge about how lineages are reprogrammed, it
might therefore one day become feasible to directly custom-
make any desired cell type in cultures or in patients.
To unravel the molecular basis of lineage reprogramming, a cell
system would be desirable where reprogramming can be induced
with high efficiency and within a short time span and cell numbers
are not limiting. Several of these requirements are met by the
conversion of primary lymphoid cells into myeloid cells. For
example, the enforced expression of C/EBPaby retroviral infection
can convert more than 60% committed B and T cell progenitors
into macrophages (Xie et al., 2004; Laiosa et al., 2006b). The
frequency of induced lymphoid to macrophage conversions is
therefore substantially higher compared to the reprogramming of
somatic cells into induced pluripotent stem cells (iPSCs) by embry-
onic stem cell-associated transcription factors (Takahashi and
Yamanaka, 2006). However, even primary lymphoid cells are not
ideal because an important fraction of the cells are resistant to re-
programming, the cultures require stromal cells, and cell numbers
are limiting. Inaddition, for everyexperiment the startingpopulation
hastobe freshly isolated frombonemarrowand infectedwith retro-
viruses, and the infected cells have to be sorted before analyses.
Here we describe a pre-B cell line that can be converted by
C/EBPa into macrophage-like cells at 100% efficiency within 2 to
3 days in the absence of stroma. The inducedcells exhibit dramatic
changes in gene expression within hours and acquire functional
macrophage properties. Time-lapse experiments showed that all
cells change in morphology and become highly motile. Further-
more, we showed that the system can be used to test for genes
with the capacity to specifically perturb cell reprogramming.
RESULTS
Pre-B Cell Lines Containing C/EBPaER Can Be Induced
to Reciprocally Regulate Lineage Marker Expression
and to Change Cell Parameters at 100% Efficiency
To develop a reprogrammable cell line system, we screened two
adult and one fetal pre-B cell lines for their ability to convert intonc.
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the problem that uninfected B cells rapidly overgrow the reprog-
rammed cells, we generated an inducible virus, containing
a fusion between C/EBPa and the estrogen hormone binding
domain (C/EBPaER), as well as GFP, as an infection marker
(Figure 1A). GFP-positive clones isolated from the lines were
infected with this virus, treated with b-estradiol, and analyzed
for Mac-1 (CD11b) and CD19 expression at different times there-
after. Clones from the fetal-derived cell line HAFTL responded
most completely and rapidly and one clone, C10, was selected
for further studies. HAFTL cells, which contain a normal, diploid
karyotype of 20 chromosomes (Figure S1 available online),
resemble pre-B cells (B220+CD19+, CD43IgM), and will be
called ‘‘B cells’’ in the following. Treatment of C10 cells with
b-estradiol induced a substantial increase in Mac-1 expression
and downregulation of CD19 already within 1 day, and after
3 days essentially 100% of the cells showed a reciprocal regula-
tion of these markers (Figures 1B and 1C). The kinetics of induced
antigen expression changes were highly reproducible, with
values varying less then 10% in repeat experiments. Induced
C10 cells showed an increase in size and granularity (Figures
1E and 1F) and most cells became adherent (Figure S2A). No
changes in antigen expression or cellular parameters were seen
in solvent-treated C10 cells (Figure 1D) or HAFTL cells treated
with b-estradiol. We also determined their growth and survival
properties. Whereas untreated C10 cells kept growing and then
slowed down after 3 days because of overcrowding, induced
cells doubled in number within the first day and then remained
quiescent. In addition, there was little increase in dead or
apoptotic cells during the 3-day observation period, although
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Figure 1. Inducible Reciprocal Regulation
of Differentiation Markers in the C10 Cell
Line
(A) C/EBPaER retroviral construct.
(B) FACS plot of Mac-1 and CD19 expression in C/
EBPaER-infected cells (C10 cell line) at different
times after induction with b-estradiol.
(C and D) Kinetics of differentiation-specific cell
surface antigens of b-estradiol-induced cells and
ethanol-treated control C10 cells, showing median
values of three separate experiments with stan-
dard deviation. Blue lines, CD19 expression; red
lines, Mac-1.
(E) Morphology of the cells before and after induc-
tion, via interference contrast microscopy. Scale
bar represents 10 mm.
(F) FACS plots showing side scatter (a measure of
granularity) and forward scatter (a measure of cell
size) of the cells shown in (B).
the cells became heterogeneous in size
and shape after prolonged culturing (Fig-
ures S2B–S2D).
To reveal structural changes, C10 cells
were induced for 3 days, fixed, stained,
and photographed with a fluorescence
microscope. Staining of mannosidase
II revealed reorganization of the Golgi
apparatus from a symmetric to a polar
structure located at one side of the nucleus, facing away from
the lamellipodium at the leading edge of the cell (Figure 2A).
Staining of F-actin revealed massive actin accumulations at the
leadingedge,while the trailingedgeshowedthe formationofstress
fibers and increased concentration of Mac-1 antigen. By contrast,
in uninduced C10 cells, both actin and CD19 antigen were
symmetrically distributed around the cell periphery (Figure 2B).
Induced Cells Exhibit Phagocytic Capacity and Respond
to an Inflammatory Stimulus
Activated macrophages are highly phagocytic and respond to
incoming bacterial pathogens with cytokine production and
inflammation (Gordon and Taylor, 2005). To test whether the
reprogrammed cells acquire these properties, C10 cells were
induced for 3 days and tested. They indeed show high phagocytic
activity when incubated withfluorescently labeledE.coli, whereas
uninduced cells were essentially negative (Figures 3A–3C). Then,
induced cells were treated with LPS or kept unstimulated. As
shown by the qRT-PCR results in Figure 3D, they responded
with a 30- to 1000-fold increased expression of RNAs encoding
TNF-a, IL-6, IL-1b, and Ccl3 (Mip1a). The data also show that
for some of these markers (IL-1b and Ccl3), the induced cells
already expressed elevated levels before LPS stimulation.
Time-Lapse Experiments Show Rapid Changes
in Morphology, Migratory Activity, and Induction
of Membrane Ruffling
Next, we performed time-lapse experiments to observe the
onset of the transition between B cells and macrophage-like
cells after activation of C/EBPa. Recordings were made atCell Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Inc. 555
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Immune Cell Reprogramming6 min intervals for 55 hr. Movie S1 shows that cells became irreg-
ular in shape, produced membrane extensions, and moved
rapidly in different directions with time. Although most of the cells
changed within 24 hr of b-estradiol treatment, some cells already
changed within 10 hr. To visualize these changes, stacks of
images captured at different time intervals were superimposed.
Figure 3E shows that the picture with the stack of superimposed
images corresponding to the 5 to 6 hr interval (bottom) closely
resembled the first image of the stack (top), i.e., showing little
motility of the cells in this time frame. In contrast, the stack
acquired at the 15 to 16 hr interval showed extensive cell move-
ments (multiple images of the same cells in different positions)
that increased further at the 24–25 and 48–49 hr intervals. The
kinetics of Figure 3F shows that the cells’ migratory activity
increased about 8-fold between 10 and 35 hr, after which it
reached a plateau. Single-cell trackings of individual cells (n =
13) showed that the onset of increased migratory activity occurred
rather abruptly at intervals between 10 and 27 hr after inducer
treatment (Figure S3). These trackings also permitted calculating
migratory activity, which was 0.26 ± 0.03 mm/min during the more
sessile phase and 1.18 ± 0.52 mm/min during the highly migratory
phase. HAFTL cells, kept with or without b-estradiol, were essen-
tially sessile. We also performed time-lapse imaging experiments
with 3-day induced cells. As can be seen in Figure 3G and Movie
S2, 72-hr induced cells exhibited membrane extensions with high
ruffling activity characteristic of macrophages.
Cells Become Transgene Independent
within 1 to 2 Days after Induction
A hallmark of transcription factor-induced cell reprogramming is
that the newly established cell phenotype becomes independent
Control cells Induced cells
B
A
Red, mannosidase II; blue, DAPI
Red, F actin; green, CD19; blue, DAPI Red, F actin; green, Mac-1; blue, DAPI
Figure 2. Changes of Cell Structures in
Induced C10 Cells
(A) Immunofluorescence staining of Golgi appa-
ratus with antibodies against mannosidase II (red)
and nuclei with DAPI (blue).
(B) Immuofluorescnce staining of cells with anti-
bodies to cell surface antigens (green), phalloi-
din-Alexa Fluor 568 for F actin (red), and DAPI for
nuclei (blue). The green fluorescence in the control
cells represents CD19 antigen; the green fluores-
cence in the induced cell represents Mac-1
antigen.
Left panels, uninduced cells; right panels, cells
induced for 3 days. Scale bars represent 10 mm.
of the inducing agent at a certain time after
induction. To test whether this is also the
case for C10 cells, they were treated
between 6 and 72 hr with b-estradiol, thor-
oughly washed, and then cultured in
absence of the inducer (Figure 4A). FACS
analyses at day 5 showed that after a 48
hr or longer induction, essentially all cells
had stably upregulated Mac-1 and down-
regulated CD19. In contrast, after a 6 hr
pulse neither of the two antigens showed
substantial changes whereas at interme-
diate induction times (12 and 24 hr),
most cells expressed Mac-1 but only some had downregulated
CD19. Differences were also seen in cell parameter changes:
whereas a 24 hr pulse was sufficient to cause an increase in
cell granularity, a 48 hr pulse was required to induce an increase
in cell volume (Figure S4). To rule out the possibility that C10 cells
treated for 24 and 48 hr eventually do revert their phenotype, they
were tested 10 days after induction, together with untreated, 6 hr
treated, and continuously treated cells as controls. As shown in
Figure 4C, almost all 48 hr treated cells were Mac-1+CD19lo cells,
resembling the continuously treated cells. In contrast, 24 hr
pulsed cells contained similar proportions of B cells and macro-
phages, whereas a 6 hr pulse is below the threshold required to
induce commitment. However, the latter cells transiently acti-
vated Mac-1, without downregulating CD19, before restoring
the original B cell phenotype. In addition, they showed a transient
increase in granularity and cell size (Figure 4B; Figure S5). These
findings show that although a 24 to 48 hr treatment with estradiol
induces transgene independence, a 6 hr pulse is not sufficient but
induces transient differentiation.
Lineage Reprogramming Is Accompanied
by the Up- and Downregulation of Multiple
Differentiation-Associated Genes
To better understand the B cell to macrophage reprogramming
mechanisms, we next analyzed the changes in global gene
expression. C10 cells were treated for different times with
b-estradiol, their RNA extracted and microarray analyses per-
formed, with Affymetrix chips that detect 45,101 probes, corre-
sponding to approximately 24,600 genes. The data obtained
were first plotted as the cumulative number of genes that
changed at least 2-fold compared to the 0 hr control cells. Within556 Cell Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Inc.
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Figure 3. Induction of Phagocytic Capacity, Inflammatory Responsiveness, as well as Cell Morphological Changes and Membrane Ruffling
Recorded by Time-Lapse Microscopy
(A–C) Phagocytosis assay.
(A and B) 72 hr induced C10 cells incubated with and without E. coli expressing dsRed, showing red fluorescence intensity.
(C) Uninduced C10 cells treated with dsRed bacteria.
(D) Effect of LPS treatment on cytokine gene expression. C10 cells were incubated with LPS for 6 hr (black bars) or left untreated (white bars) and RNAs analyzed
by qRT-PCR for tnf (TNF-a), il6, il1b, and ccl3 (Mip1a).
(E) Imaging of cells at different stages of induced reprogramming. C10 cells treated with b-estradiol were recorded by time-lapse microscopy at 6 min internals
for 55 hr. The images were taken from Movie S1. The upper panels show images of cells at the indicated time points in white; the lower panels represent stacks of
10 superimposed pictures corresponding to 1 hr intervals, indicated in black.
(F) Relative cell migration activity of the cells from Movie S1.
(G) Membrane ruffling activity of C10 cells induced for 72 hr, showing green fluorescent images taken at the intervals indicated in Movie S2.3 hr 1038 genes became upregulated and 1401 downregulated,
and within 48 hr a total of 4468 genes changed (Figure S6A).
Genes that changed during reprogramming across all time points
were subjected to unsupervised hierarchical clustering, gener-
ating an expression tree that showed the expected relationships
between the different time points (Figure S6B). We then arrayed
the genes in this tree in a horizontal fashion, providing an overview
over the gene expression changes (Figure 5A). Four groups of
genes could be discerned: (1) upregulated genes, (2) downregu-
lated genes, (3) genes that first became up- and then downregu-
lated, and (4) genes that were first down- and then upregulated.
Analysis of the kinetics of genes encoding known macrophage
and B cell functions supported the prediction that they are con-
tained in groups 1 and 2, respectively. We also verified that these
genes differed accordingly between two sets of control arrays:
primary pre-B cells and bone marrow-derived macrophages on
the one hand, and the pre-B cell line HAFTL and the macrophage
lineRAW 264.7 onthe other. Among the upregulated macrophage-Cassociated genes were lysozyme (lyzs), CSF-1 receptor (csf1r),
macrophage scavenger receptor 1 (msr1), Fc gamma receptor
1 (fcgr1), and Mac-1 (itgam) (Figure 5B; Table S1). Furthermore,
we found toll receptors (tlr2,cd14); the scavenger receptor/phago-
cytosis gene cd36; interferon response genes (ifitm3, ifitm6);
chemokines and chemokine receptors (ccl9, ccr1); lysosomal
proteins (ctsb); metalloproteinases (mmp12, mmp13); inflamma-
tory response genes (il6, il1b, and ccl3); and cyclooxygenase 2
(ptgs2) among the upregulated genes (Table S1 and Figure S7).
Many of these genes are known to be direct targets of C/EBPa,
PU.1, and Pax5 (Table S1). The downregulated B cell lineage-
associated genes included the recombination activation genes
rag1 and rag2 as well as several members of the B cell receptor
complex, cd79a, ighg, and vpreb1 (Figure 5B; Table S1). In addi-
tion, they included genes involved in cell adhesion (slamf6 and
cxcr4) and cytokine binding (il7r), which have been described as
Pax5 targets (Pridans et al., 2008; Schebesta et al., 2007). The
downregulation of rag1 and the upregulation of lysozyme andell Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Inc. 557
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Immune Cell ReprogrammingCSF-1 receptor genes were verified by qRT-PCR (Figure 5C).
Some genes changed without showing significant differences
between control B cells and macrophages. Among the downregu-
lated genes, many were found to be involved in cell cycle control
whereas the upregulated genes included seven members of the
schlafen family, associated with growth arrest (Brady et al., 2005).
An Ingenuity software analysis of the genes with more complex
regulation revealed that group 3 genes were broadly enriched for
functions involved in inflammatory response, cell death, cellular
growth and proliferation, antigen presentation, cellular develop-
ment, and cell-cell interaction (p values between 1011 and 108).
Group 4 genes showed a strong enrichment for cell cycle, DNA
replication, recombination and repair, RNA posttranscriptional
modification,cellularassemblyandorganization,andcell-mediated
immune response (p values from 1047 to 108). No change was
seen in the expression of progenitor genes such as Kit and Sca-1.
We also tested for the requirement of protein synthesis of the
differentiation-associated genes (groups 1 and 2). Of 10 genes
tested that became down- or upregulated within 3 hr, 8 changed
even in the presence of cycloheximide (cd79b, cxcr4, il7r, cd14,
fcgr1, ptgs2, ifitm6, and csf1r) (Figure S8), suggesting that they
are direct targets of either Pax5 or the C/EBPa-PU.1 complex,
whereas csf2r2a and msr1 are probably regulated by a down-
stream effector.
The changes observed in the cell line resembled the changes
induced in primary pre-B cells infected with C/EBPaER and
6hr
12hr
24hr
36hr
48hr
60hr
72hr
cont.
0
20
40
60
80
100
0
20
40
60
80
100
0      1      2      3      4      5 0      1      2      3      4      5
%
 C
D
19
 p
os
. c
el
ls
%
 M
ac
-1
 p
os
. c
el
ls
A
0 4 5
B
C
Days after beginning of induction
CD19 Hours of estradiol treatment 
0 6 24 48 cont.
M
ac
-1
1 2 3
6
12
24
36
60
48
72
cont.
Days after beginning of induction
Figure 4. Induction of Transgene Indepen-
dence
(A) Experimental setup of the experiment, showing
in different colors the time of b-estradiol treatment
of C10 cells before washing the drug out.
(B) Kinetics of Mac-1 (left) and CD19 expression
(right) of C10 cells treated for different times with
the inducer and then washed out.
(C) FACS profiles of differentiation antigens of C10
cells treated with b-estradiol for different times
and analyzed 10 days after beginning of induction.
Cont., continuous treatment with the inducer.
induced with estradiol, except that the
latter were slightly slower (Figure 5D).
Finally, we also performed a chromatin
immunoprecipitation analyses of histone
modification kinetics of the promoter of
a characteristic macrophage gene (it-
gam, Mac-1) and a B cell gene (rag1).
The two genes showed the expected
changes over time in the activation mark
H3K4me3 and the repression mark
H3K27 (Figures S9A and S9B).
Lineage Regulators of Known
and Unknown Functions
Change Expression
To determine the changes in regulatory
networks of B cells and macrophages,
we analyzed our expression database
for key transcription factors controlling
these two lineages. Four groups of factors became upregulated
(Figure 6 and Table 1A). (1) Genes directly regulated by PU.1
including sfpi1 (PU.1) itself, which is also regulated by C/EBPa
(Friedman, 2007), as well as id2, klf7, nab2, and gfi1. Gfi-1 is
also a target gene of C/EBPa (Weigelt et al., 2008, 2009) and
a known inducer of granulocyte development (Laslo et al.,
2006). It first became up- and then downregulated as nab2
became upregulated. Nab2 is an antagonist of Gfi-1 that
represses granulocyte fate and specifies macrophages (Laslo
et al., 2006), so this could explain why C/EBPa-induced B cells
ultimately acquire a macrophage phenotype. (2) C/EBP family
members. As shown in Figure 6B, cebpb and cebpd became up-
regulated while cebpg was slightly downregulated. C/EBPb and
C/EBPd are known to have roles in myelomonocytic cell function
and development (Friedman, 2007) whereas C/EBPg is a domi-
nant-negative inhibitor of the other family members (Cooper
et al., 1995). Surprisingly, cebpa remained silent within the time
frame tested and became upregulated only between 4 and
5 days after induction of C10 cells (data not shown). (3) AP-1 family
members jun, junb, fos, and fosl2 (Figure 6C). These factors are
capable of regulating myeloid genes by forming heterodimers
with C/EBPa (Cai et al., 2008). (4) Candidate macrophage regula-
torsets2,mef2a,mitf, rbpj,nfil3, and tcfec (Table 1A; Figure S10A).
Changes in expression of selected transcription factor genes
(sfpi1, gfi1, cebpb, cebpd, and mitf) were also tested by qRT-
PCR in 3 hr stimulated cells, with and without cycloheximide. No558 Cell Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Inc.
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two conditions (Figure S11), supporting the idea that these genes
are direct targets of the PU.1/C/EBPa complex.
Another four groups of genes became downregulated and
showed differences in expression consistent with those seen
with the B cell and macrophage control sets (Table 1B). (1) Genes
encoding the B cell master regulators Pax5, EBF, and E2A
became downregulated more than 2-fold already within 3 hr after
induction (Figure 6D). This probably reflects the fact that C/EBPa
directly inhibits Pax5 (Xie et al., 2004) and that Pax5 regulates ebf
and tcfe2a as well as itself (Pridans et al., 2008; Schebesta et al.,
2007). (2) Additional genes regulated by Pax5 and which play
a role in B cell development. These comprise spib, ikzf3 (zfpnia3,
aiolos), lef1, bach2, irf4, and irf8 (Figure 6E; Pridans et al., 2008;
Schebesta et al., 2007), with irf8 showing bimodal kinetics,
perhaps reflecting its dual role in B cell and macrophage/
dendritic cell development (Wang and Morse, 2008). (3) Genes
that have been implicated in B cell development but whose regu-
lation is less well understood. These include foxo1, sox4, bcl11a,
and myb (Figure 6F; Busslinger, 2004; Dengler et al., 2008;
Thomas et al., 2005). (4) Genes with a suggested role in B cell
development and/or function: aff3, hes1, ets1, erg, trib2, and
zfp507 (Table 1B; Figure S10B). A selection of these genes
was tested for protein synthesis dependence by inducing C10
cells for 3 hr with and without cycloheximide. spiB, lef1, irf8,
foxo1, and bcl11a were found to be downregulated within 3 hr
under both conditions (Figure S13), in line with the possibility
that they are direct targets of Pax5.
Our earlier work with primary cells indicated that the two key
effectors targeted by C/EBPa during the reprogramming of B
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Figure 5. Global Changes of Gene Expression during Induced Reprogramming
(A) Diagram showing unsupervised hierarchical clustering of 10,892 probes corresponding to 6,687 genes that change at least 2-fold across all conditions. The
time course is displayed from top to bottom. Each vertical line represents a different probe. The bars represent Affymetrix expression values (log2) relative to the
median value of each probe (set at 0) across the various time points. The black bars represent values below the median, the red bars above the median.
(B) Kinetics of regulation (log2 Affymetrix expression values) of macrophage (left) and B cell genes (right) in C10 cells treated with b-estradiol for the times
indicated.
(C) qRT-PCR kinetics of gene expression of selected macrophage and B cell genes. The values are relative to the expression of gusb RNA in the same samples.
(D) Same as in (C), but with RNAs from primary pre-B cells infected with C/EBPaER and induced by b-estradiol for the times shown. The horizontal, colored lines
indicate levels of expression of the corresponding genes in bone marrow-derived macrophages.Cell Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Inc. 559
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Immune Cell Reprogrammingcells into macrophages are PU.1 and Pax5 (Xie et al., 2004). In
addition, differences in PU.1 expression level are thought to be
key for the cells’ fate determination, with moderate levels being
required for B cell formation and high levels for macrophage
formation (DeKoter and Singh, 2000). As expected, array
data showed a reciprocal regulation of the two factors during
the induced reprogramming (Figures 6A and 6D). To verify these
data, we also performed qRT-PCR and western blotting.
Although both techniques yielded qualitatively similar data (Fig-
ures 6G and 6H), there were much larger expression differences
at the protein level than at the RNA level, suggesting that both
PU.1 and Pax5 proteins are rapidly degraded.
A Number of Chromatin-Associated Factors Become
Downregulated
Of 162 genes encoding chromatin-associated factors, none
were found to be upregulated. However, we found 15 that
were downregulated in a manner consistent with the differences
seen between both sets of B cell and macrophage controls. They
included the polycomb complex II component ezh2 and the DNA
methyltransferase Dnmt3b (Table 1C). qRT-PCR confirmed
that ezh2 is downregulated within 3 hr of induction, even in the
presence of protein inhibition (data not shown). This raises the
possibility that ezh2 is directly regulated by either C/EBPa/
PU.1 or Pax5.
An Assay for Genes that Affect Immune Cell
Reprogramming
The data described show a number of unexpected transcription
and chromatin-associated factors that are differentially regu-
lated and that may play a role in reprogramming. We therefore
tested whether overexpression of known B cell regulators or
the knockdown of a myeloid regulator inhibits the up- or down-
regulation of C/EBPa-induced expression of CD19 and Mac-1,
as expected. To do this we first infected C10 cells with a retro-
virus containing shPU.1 or a scrambled version of the shRNA.
Cells were then induced with b-estradiol continuously or for
24 hr and analyzed at various times thereafter for the expression
of differentiation antigens. Continuous or pulsed b-estradiol
induction of these cells showed that the PU.1 knockdown in-
hibited Mac-1 upregulation, while not affecting CD19 downregu-
lation (Figure 7A), a finding that confirms experiments obtained
with primary pre-B cells in which PU.1 was ablated (Xie et al.,
2004). We next tested the effects on induced reprogramming
of Pax5, EBF, and E2A (E47) transcription factors, three well-
established B cell regulators (Laiosa et al., 2006a). For these
experiments, we developed retroviral constructs containing
GFP as an infection marker as well as another HAFTL cell-
derived clone (C11) that expresses a truncated human CD4
as an infection marker, in addition to C/EBPaER. Continuous
b-estradiol treatment of C11 subclones expressing one of each
C
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Figure 6. Changes in Transcription Factor Gene Expression during Induced Reprogramming
(A–F) Upregulated (A–C) and downregulated (D–F) genes.
(G) Expression kinetics of Pax5 and PU.1 as determined by qRT-PCR.
(H) Western blot of Pax5 and PU.1 in uninduced C10 cells () or treated with b-estradiol for 3 days (+). Also shown are HAFTL B cells and RAW macrophages as
controls. bTub., b-tubulin used as loading control.560 Cell Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Inc.
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Immune Cell ReprogrammingTable 1. Expression Changes in Transcription Factor and
Chromatin-Associated Factor Genes
Gene 48 hr/0 hr
Mac/
Pre-B
RAW/
HAFTL
(A) Upregulated Transcription Factor Genes
(1) Regulated by PU.1 Sfpi1 2.1 1.2 1.3
Id2* 3.1 0.5 2.0
Klf7* 1.9 0.9 0.9
Nab2 2.4 1.7 0.8
Gfi1 1.1a 5.6 1.7
(2) C/EBP family Cebpa 0.1 1.6 2.9
Cebpb* 3.4 0.7 3.1
Cebpd* 7.0 3.6 4.2
(3) AP-1 family Fos 6.4 1.1 7.0
Fosl2 6.7 3.6 5.2
Jun 3.2 3.3 0.7
Junb 1.7 3.6 2.3
(4) Suspected role in
macrophage differentiation
Ets2 1.8 0.7 3.4
Mef2a 1.1 2.4 2.0
Mitf 2.0 5.5 5.1
Rbpj 1.8 3.5 3.6
Nfil3 4.1 2.3 3.7
Tcfec 4.6 3.5 3.4
(B) Downregulated Transcription Factor Genes
(1) B cell master regulators Pax5* 3.1 5.4 5.4
Ebf1* 2.6 6.0 6.0
Tcfe2a* 2.5 2.3 2.3
(2) Regulated by Pax5 Spib 4.6 6.9 6.9
Ikzf3 4.8 6.5 6.5
Lef1* 3.5 1.7 1.7
Bach2* 4.8 8.1 8.1
Irf4 2.4 4.7 4.7
Irf8 0.2b 1.9 1.9
(3) Implicated in B cell
differentiation
Foxo1* 4.1 2.2 2.2
Sox4* 3.6 6.3 6.3
Bcl11a 4.4 4.5 4.5
Myb* 3.6 5.7 5.7
(4) Suspected role in B cell
differentiation
Aff3 5.1 4.9 4.9
Hes1 2.2 3.2 3.2
Ets1 1.8 7.4 7.4
Erg 3.5 2.9 2.9
Trib2 3.4 5.8 5.8
zfp507 4.1 3.9 3.9
(C) Chromatin-Associated Factors
Cbx1 1.3 2.1 1.0
Cbx5 1.4 1.4 1.7
Chd1 1.2 1.3 0.5
Dnmt3b* 2.3 0.7 2.1
Ezh2 2.3 2.6 1.3
Hdac11 3.3 1.9 1.5Ceof the three transcription factors showed that Pax5 delayed both
CD19 downregulation and Mac-1 upregulation for one and a half
days, EBF caused a mild inhibition of Mac-1 upregulation, and
E47 had no effect; similar but more dramatic results were ob-
tained with the 24 hr induction protocol (Figure 7B). The assay
also showed a dosage effect of the counteracting transcription
factors, with cells expressing the highest levels of Pax5 and
EBF (as detected by GFP) showing the strongest inhibitory
effects and high levels of E47 showing a weak effect (Figure S12).
DISCUSSION
Our data have shown that the C/EBPaER-expressing B cell line
C10 represents a robust, highly efficient, and reproducible
system to study transcription-factor-induced reprogramming
of immune cells. After treatment with b-estradiol, the cells
show reciprocal changes in lineage-specific cell surface anti-
gens in a highly reproducible manner. They become granulated,
increase in size, exhibit phagocytic capacity, respond to an
inflammatory stimulus, develop membranes with ruffling activity,
and increase their migratory activity. In addition, they up- or
downregulate thousands of genes, including many that are
restricted to B lineage cells and macrophages. For the following
reasons we conclude that all cells of the C10 cell line become
reprogrammed. (1) Essentially 100% of the cells show a recip-
rocal regulation of CD19 and Mac-1 antigens. (2) There is no
evidence of apoptosis during the reprogramming, arguing
against a selection of reprogrammed cells. (3) The observation
that C10 cells consist exclusively of macrophages when cultured
for 2 to 3 weeks shows that the system is tight. In this culture
period, even a small proportion of nonresponding B cells, which
are highly proliferative, would have overgrown the cultures. The
Table 1. Continued
Gene 48 hr/0 hr
Mac/
Pre-B
RAW/
HAFTL
Hdac8 1.3 0.8 0.8
Hmgb1* 1.5 1.5 2.1
Hmgb2* 1.4 1.6 1.5
Jarid1a 1.0 0.6 1.0
Mtf2* 1.5 1.8 1.9
Smarca4 1.3 2.3 1.3
Smarca5 1.1 1.4 1.0
Smarcc1 1.6 2.6 1.5
Whsc1 1.0 0.8 1.6
(A and B) Upregulated (A) and downregulated (B) transcription factor
genes.
(C) Chromatin-associated genes.
The columns list, in this order: groups of regulated genes, gene names,
the ratios of Affymetrix expression units (log2) of 48 hr induced C10 cells
over uninduced cells, ratios of bone-marrow-derived macrophages
over pre-B cells, and ratios of RAW macrophages over HAFTL B cells.
Asterisks denote genes for which several Affymetrix probes showed
similar behavior.
a At intermediate time points, gene is upregulated at higher levels.
b At intermediate time points, gene is downregulated at lower levels.ll Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Inc. 561
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Immune Cell ReprogrammingFigure 7. Effects of Transcription Factor Perturbations on Reprogramming
(A) C10 cells stably expressing either shPU.1, a scrambled sh sequence, or control C10 cells were treated with b-estradiol either continuously or for 24 hr. They
were then analyzed by FACS after staining with antibodies to CD19 and Mac-1 at various days thereafter. Expression of PU.1 in knockdown cells was about 60%
of WT levels as estimated by qRT-PCR (data not shown). Similar effects on differentiation as shown were obtained with a second shPU.1 construct.
(B) C11 cells were infected with Pax5-GFP, EBF-GFP, or E47-GFP viruses, induced with b-estradiol, and analyzed as above. Cells within the GFP-positive
and -negative fractions were gated and the results plotted.advantage of the observed high switching frequency, combined
with the fact that the system requires no stromal cells, is that
mechanistic analyses can be performed without having to
cope with heterogeneity of the starting population. In addition,
the tightness of the switching permits us to perform gene pertur-
bation experiments without confounding effects of nonrespond-
ing B cells.
The time-lapse experiments also support the conclusion that
C/EBPa induces a fate change in 100% of the cells (Figure S3).
In addition, of the seven cells tracked individually, six divided
before changing morphology/motility. The tracking data support
the observation that the population doubles once becoming
quiescent (Figure S4). It will be interesting to determine whether
reprogramming of B cells requires cell division.
During reprogramming, the cells become highly asymmetric in
that their Golgi apparatus forms a perinuclear structure facing
the cell’s actin rich leading edge. Such a polarity was also
seen in a subset of normal macrophages. Cell polarity is known
to be mediated by the activation of Rho GTPases through GTP
exchange factors (Heasman and Ridley, 2008). Therefore, it is562 Cell Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Inpossible that the high degree of the polarization in the reprog-
rammed cells is mediated by the Ha-Ras oncoprotein used to
immortalize the original HAFTL B cell line (Alessandrini et al.,
1987), as shown by the fact that Ras can activate Rho GTPases
(Sahai and Marshall, 2002). This polarization might be the cause
for the high migratory activity, normally seen with myeloid
dendritic cells or with macrophages exposed to external stimuli
such as bacteria or LPS (Lim et al., 2008).
The vast majority of functional genes characteristic for B cells
and macrophages tested were correctly up- or downregulated,
showing that the C10 cell model can be used to study the tran-
sition between the two lineages. Induced C10 cells also downre-
gulate many genes that were found to have a role in the cell
cycle, likely reflecting the fact that C/EBPa is a strong cell cycle
inhibitor through inactivation of E2F (Porse et al., 2001). How-
ever, there were also important differences to normal macro-
phages. Thus, of the 500–700 genes whose expression was
found to differ consistently between adult macrophages and
B cells, only approximately half were regulated after a 48 hr
induction of C10 cells. That this number was not higher mightc.
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analyzed, variability in gene expression inherent to cell lines, or
the fetal origin of HAFTL/C10 cells, because fetal macrophages
are known to differ from adult ones (Faust et al., 1997).
The C/EBPa-induced effects on gene expression are remark-
ably fast, with more than 2000 genes changing expression within
only 3 hr and the first cells exhibiting a macrophage morphology
as early as 10 hr. In spite of this, a 6 hr treatment of C10 cells with
b-estradiol was not sufficient to induce transgene indepen-
dence, with cells showing a transient increase in Mac-1 expres-
sion as well as granularity (Figure 4B; Figure S7). The finding that
it takes approximately 24 hr of C/EBPa activation to stably
downregulate CD19 (Figure 4B) suggests that the rate-limiting
step for the fate transition is the collapse of the B cell program.
This might be because higher concentrations of C/EBPa are
required to disrupt Pax5 autoregulation than the amounts neces-
sary to activate myeloid genes. More generally, the observation
that transgene independence can be induced in all cells by a
48 hr exposure to the inducer shows that C/EBPa truly induces
reprogramming and not merely maintains an altered gene
expression program. This distinguishes it from fibroblasts con-
verted into macrophage-like cells by the ectopic expression of
PU.1 and C/EBPa, whose phenotype remains dependent on
the activity of the two genes (Feng et al., 2008; and unpublished
observations).
During the reprogramming experiments in which cells were
exposed to variable times to the inducer, we never found any
stable intermediates, as has been described for fibroblasts and
mature B cells exposed to Oct4, Sox2, Klf4, and Myc (Hanna
et al., 2008; Mikkelsen et al., 2008; Wernig et al., 2008). In addi-
tion, in contrast to the 1 to 2 days of treatment with the inducer
required to induce transgene independence in the B cell system,
it takes about 10 days for stable iPS reprogramming (Stadtfeld
et al., 2008; Wernig et al., 2008). These observations, together
with the finding that most genes whose expression changes
are directly up- or downregulated, suggest that reprogramming
of B cells into macrophages is direct and differs from reprogram-
ming of B cells into iPSCs induced by Oct4/Sox2/Klf4/Myc
(Hanna et al., 2008).
The reprogramming counteraction assay developed shows
that the system can be used to screen for genes that either selec-
tively inhibit B cell extinction or myeloid gene activation, or both.
For example, as expected, shPU.1 selectively blocked Mac-1
upregulation. The finding that Pax5 inhibited the reciprocal
C/EBPa-induced regulation of both CD19 and Mac-1 indicates
that besides maintaining the B cell program it cross antagonizes
the myeloid regulator C/EBPa, consistent with previous results
(Xie et al., 2004). In contrast, the observed selective inhibition
of CD19 downregulation by EBF suggests that it counteracts
PU.1 but not C/EBPa. Finally, the finding that E47 is essentially
innocuous suggests that it is not sufficient to induce and main-
tain the expression of its downstream targets EBF and Pax5. It
will now be interesting to determine whether combinations of
Pax5, EBF, and perhaps E47 are capable of reverting fully differ-
entiated macrophages into B cells.
The efficiency, tightness, rapidity, stromal independence, and
availability of essentially unlimited cell numbers makes the
system described uniquely suited for biochemical and biological
experiments on lineage reprogramming. It could be used toCaddress a wide range of questions, such as determining the
role of epigenetic changes (histone modifications, nucleosome
remodeling, DNA methylation) and their interplay with transcrip-
tion factors, assessing the contribution of noncoding RNAs and
determining whether lineage reprogramming leads to altered
chromosome territories (Parada et al., 2004). Further, it lends
itself for screening of genes or substances that counteract or
accelerate lineage reprogramming or inhibit leukemogenicity of
lymphoid leukemias by inducing differentiation. It could also be
used for screening or testing the function of genes required for
cytoskeletal and organelle organization and the machineries
needed for phagocytosis, inflammatory response, and secretion.
Finally, the system is well suited to determine whether cell divi-
sion is necessary for lineage reprogramming. Together, these
experiments should not only provide new insights into how one
cell is converted into another but also help develop novel
approaches to custom design cell types desired for cell therapy.
EXPERIMENTAL PROCEDURES
Cells
HAFTL cells are a fetal-liver-derived, Ha-ras-oncogene-transformed mouse
cell line (Alessandrini et al., 1987), provided by Dr. B. Birnstein. Dr. D. Cox
provided the RAW 264.7 mouse macrophage cell line. Normal macrophages
and pre-B cells were derived from bone marrow as described (Xie et al., 2004).
C/EBPaER Retrovirus and Stably Expressing HAFTL Cell Clones
The MSCV C/EBPaER IRES GFP virus was constructed by removing C/EB-
PaER from pBabe-C/EBPaER (Wang et al., 2001) with EcoRI and ligating it
to the MSCV-IRES-GFP vector opened with the same enzyme. A similar
approach was used with the C/EBPaER hCD4 retrovirus. The C10 and C11
clones stably expressing these two viruses were obtained after infection of
HAFTL cells and seeding the cells singly into 96-well plates.
Assay for Genes Involved in Lineage Reprogramming
C10 were infected with a retrovirus containing either an shPU.1 or a scrambled
sequence, plus a puromycin-resistant gene (Sigma, Clone ID NM_011355.1-
501s1c1), and puromycin-resistant cells were isolated. These cells were
then treated with b-estradiol either for 24 hr and then washed, or continuously
treated, and CD19 and Mac-1 expression were monitored at various time
intervals by FACS. Pax5-EGFP-, EBF-EGFP-, and E47-EGFP MSCV-based
retroviruses were used to infect C11 cells, the cells induced with b-estradiol
as above, and GFP-positive and -negative cells analyzed by FACS.
Induction of Reprogramming and Cell Growth Assays
C10 and C11 cells were grown in RPMI 1640 without phenol red (Lonza)
supplemented with 10% charcoal/dextran-treated FBS (Hyclone) and 50 mM
2-mercaptoethanol (GIBCO), incubated at 37C in 5% CO2. They were
induced by the addition 100 nM of b-estradiol (Calbiochem) and grown with
10 nM of IL-3 and CSF-1 (Peprotech). Control cells were treated with 0.1%
ethanol (solvent). Staining for cell surface antigens was with directly conju-
gated antibodies against Mac-1 and CD19 (BD PharMingen). Cells were
analyzed with a FACSCanto flow cytometer (BD Biosciences, San Diego,
CA), via FlowJo software (Tree Star, Ashland, OR). FACS was also used to
determine forward and side scatter. To determine the growth kinetics, 53 105
C10 cells were seeded in 24-well plates and counted at daily intervals,
excluding dead cells by trypan blue staining.
Viability and Apoptosis Assays
For viability assays, C10 cells were incubated with 1 mg/ml 7-AAD (BD) for
30 min on ice in the dark. To determine the proportion of apoptotic cells, cells
were permeabilized and stained with affinity-purified rabbit IgG antibodies to
activated caspase 3 (Cell Signaling Technology, Beverly, MA), detected with
AF647 goat anti-rabbit antibodies (Invitrogen). Both sets of experimentsell Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Inc. 563
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above.
Phagocytosis Assay
C10 cells were seeded into 6-well plates and treated with 100 nM of b-estradiol
for 72 hr or left untreated. Then 100 dsRed E. coli per cell were added and
plates centrifuged at 800 3 g for 5 min. Thereafter cultures were incubated
with 400 mg/ml gentamycin for 3 hr at 37C to eliminate extracellular bacteria.
To remove excess bacteria from adherent cells, they were washed three times
with PBS and cells trypsinized. For nonadherent cells, a 2 ml cell suspension
was underlayered with 5 ml of fetal calf serum and kept at room temperature
for 2 hr. Cells were collected from the serum phase, centrifuged, and FACS
analyzed together with the trypsinized cells.
Karyotype Analysis
The karyotype of HAFTL cells was determined by color karyotyping and eval-
uating 10 metaphase spreads (Chrombios Molecular Cytogenetics, Raubling,
Germany).
Inflammatory Response Experiments and qRT-PCR
C10 cells were deprived of CSF-1 for 16 hr and then incubated with LPS (1 mg/
mL Sigma) for 6 hr. RNA from triplicate samples was extracted with RNeasy
Minikit (QIAGEN) and reverse transcribed with GeneAmp RNA PCR (Applied
Biosystems). SybrGreen PCR Master Mix (Applied Biosystems) was used for
amplification and detection of cDNAs, and PCR reactions were carried out
with the AB7900HT detection system (Applied Biosystems). Ct values were
calculated and normalized to Gusb, and the relative expression ratio was
calculated by the Pfaffl method (Pfaffl, 2001). Primer sequences are provided
on request.
Staining for the Golgi Apparatus and Actin Cytoskeleton
To stain the Golgi apparatus, cells were fixed in paraformaldehyde, permeabi-
lized in PBS-BSA-triton (13-0.5%–0.3%), and incubated with monoclonal
antibodies against mannosidase II conjugated with phycoerythrin (Covance)
before counterstaining the nuclei with DAPI. To visualize F-actin, cells were
first stained with either CD19 or Mac1 antibodies (see above) and then fixed
with 4% paraformaldehyde for 20 min at RT, followed by a 30 min block with
1% BSA in PBS. After permeabilizing the cells with PBS-BSA-triton for
30 min at RT, they were stained with Alexa Fluor 568-coupled phalloidin
(Molecular Probes, Invitrogen) for 20 min at RT in the dark. Finally, they were
counterstained with DAPI. All images were acquired with an SPE confocal
microscope and processed with Adobe Photoshop software.
Time-Lapse Experiments
For the experiments to visualize the reprogramming of B cells into macro-
phages, C10 cells were seeded in an 8-well ibiTreat microscopy chamber
(Ibidi) and treated with b-estradiol, and images were acquired with a 203 0.5
NA phase objective at 6 min intervals (Movie S1) or a 103 0.3 NA phase objec-
tive (Movie S2) at 3 min intervals. There was an approximately 1 hr delay
between adding of the drug and the beginning of the recording. Image J soft-
ware was used to process the movies. The kinetics of Figure 3D were deter-
mined by comparing the differences in space occupancy between adjacent
time points, correcting for the increase in cell size over time. For the membrane
ruffling experiments, C10 cells were treated with b-estradiol for 3 days, seeded
on a coverslip, and observed in a Cell Observer Microscope (Zeiss) equipped
with an EMBL microscope incubator box (EMBLEM). Images were taken at
1003 every 10 s.
Pulse Induction Experiments
C10 cells seeded in medium containing 10 ng/ml rIL-3 and 10 ng/ml rCSF-1
(Preprotech) were treated with b-estradiol for various periods of time and
then washed three times in PBS before adding fresh medium plus cytokines
but without inducer. They were then analyzed at consecutive days by FACS.
Gene Expression Profiling by Microarrays
Biological duplicates of C10 cells were incubated with 100 mM b-estradiol and
harvested for RNA extraction at various times thereafter. Uninduced C10 cell
controls were maintained for 48 hr in 0.1% ethanol. Total RNA was extracted564 Cell Stem Cell 5, 554–566, November 6, 2009 ª2009 Elsevier Inwith Trizol reagent and RNA purified. The quality of the RNAs was determined
by Bioanalyzer (Agilent 2100), biotynilated, and amplified in two cycles. Dupli-
cate samples of the HAFTL B cell line, freshly isolated pre-B cells, and the RAW
macrophage cell line were used to prepare control RNAs. The amplified RNAs
were hybridized against Affymetrix 430.2 mouse arrays.
Bioinformatic Analyses
Affymetrix DAT files were processed with the Affymetrix-Gene Chip Operating
System (GCOS) to create .CEL files. Quality control of the array hybridization
was performed through Bioconductor (release 2.2) in the R statistical environ-
ment (version 2.7.0) via the Amarge package. This consisted in visual examina-
tion of hybridization chip images, scatter plots from replicates, RNA degrada-
tion plots, RLE and NUSE plots, as well as 30 to 50 ratios of actin and GAPDH.
Normalization of the raw Affymetrix expression data was performed by Robust
Multi-chip Analysis (RMA) (Irizarry et al., 2003) via the Affy package. Normal-
ized log2 scaled values were then averaged, and ratios were calculated to
isolate probes showing an at least 2-fold change. Hierarchical clustering of
the Affymetrix data was performed with Cluster software (version 3.0) and
represented with Treeview software. The clustering algorithm (UPGMA) was
used in a centroid linkage fashion on the probes showing an at least 2-fold
change, after being centered to the median. Functional analyses of the
different genes clusters was performed with Ingenuity Pathway Analysis
(version 7.5) with the Core Analysis module and default parameters to obtain
the enrichments and p values of functional categories for each set of genes.
Chromatin Immunoprecipitation
C10 cells treated for 0 to 120 hr, HAFTL, and RAW cells were crosslinked with
1% formaldehyde and subjected to chromatin immunoprecipitation (ChIP)
after sonication. Antibodies against trimethyl K4 of histone H3 (Abcam) and
trimethyl K27 (Millipore) of histone H3 were used. Data are represented as
the ratio between the ‘‘bound’’ fraction for the histone modification antibody
versus the ‘‘bound’’ fraction of the C-t histone H3 (total) antibody. Two genes
were tested, itgam (Mac-1), whose expression increases during reprogram-
ming, and Rag1, which is repressed during reprogramming. The primers
used for Mac-1 were GGTGTAACCCTGATGGTTCG and AGGAGGGAGGGGT
AAAAAC, yielding a 159 bp product. For Rag-1 they were TTTCCACCGTAGG
CATTCTC and TAGCCAATCACAGACCAGCA, yielding a 152 bp product.
Results shown were obtained by real-time PCR.
Protein Synthesis Requirement
C10 cells were preincubated for 30 min with cycloheximide (10 mg/ml) and then
b-estradiol added for another 3 hr. Cells were harvested and RNA extracted
and processed by qRT-PCR in triplicate as above. The Ct values for treated
and nontreated samples were expressed relative to the 0 hr time point. Primer
sequences are provided on request.
Western Blotting
Cellular extracts were prepared in 0.5% Triton X-100, 0.5 mM EDTA, 1 mM
DTT in PBS, and protease inhibitors (Complete, Roche Molecular Biochemi-
cals). Cell lysates were electrophoresed and western blotted according to
standard procedures. The blots were developed with the ECL detection kit
(Amersham Pharmacia Biotech). Anti-PU.1 (sc-352) and anti-Pax5 antibodies
were from Santa Cruz Biotechnology; anti-tubulin antibody was from Sigma.
ACCESSION NUMBERS
Microarray data were deposited in the GEO database with accession number
GSE17316.
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